Value202020212022202320242025TTMCash from investing activities159.44 M632.37 M517 K76.71 M12.86 M12.34 M12.34 MCash from financing activities235.6 M725.28 M11.83 M4.55 M4.65 M200.29 M200.29 MFree cash flow-27.64 M-37.42 M35.1 M-26.8 M-34.04 M-21.78 M-21.78 M
NeoGenomics Inc
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.